News
New weight loss pill could benefit people with Type 2 diabetes: Drugmaker
Drugmaker Eli Lilly said that in Phase 3 studies of over 550 adults, their oral GLP-1 pill, orforglipron, could reduce hemoglobin A1C levels on average by 1.3-1.6% and also help people lose up to 16 pounds, or about 7.9% of their body weight.
Live Science on MSN1d
Ozempic pill? Trial suggests new oral drug works as well as injectables for type 2 diabetesThe drugmaker Lilly announced topline results of a clinical trial of a new pill in the same drug class as injectables like ...
Drug manufacturer Eli Lilly announced this week that an encouraging clinical trial of their new pill promises a convenient, ...
Researchers at Mass General Brigham found that by December 2023, over one-third of all new prescriptions for type 2 diabetes ...
Older adults living with Type 2 diabetes face more than just blood sugar concerns. New research shows some of the most ...
MedPage Today on MSN3d
Diabetes, Heart Disease Drugs Recalled; New Trump Order; Maple Syrup's Health ClaimsMedPage Today is collecting stories of HHS staffers across all agencies affected by Trump administration cuts. If you want to ...
“Our CB-SCs can target different compartments of the immune system, educating and correcting their dysfunctions at a fundamental level,” says Dr. Zhao. “This therapy has the potential to revolutionize ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback